Archived [2022-03-21] Summary report November 22, 2012 - Chemicals Management Plan Stakeholder Advisory Council
Chemicals Management Plan Stakeholder Advisory Council Meeting
- David Morin (Director General, Science and Risk Assessment, Environment Canada [EC])
- Karen Lloyd (Director General, Safe Environments Directorate, Health Canada [HC])
- Council members present:
- Susan Abel
- Andrew Black
- Shannon Coombs
- Amardeep Khosla
- Gary LeRoux
- Gordon Lloyd
- Eric Loring
- Maggie MacDonald
- Sandra Madray
- Mary Richardson
- John Skowronski
- Dr. Don Spady
- Government officials present:
- Greg Carreau (Executive Director, Program Development and Engagement Division, EC)
- Vincenza Galatone (Executive Director, Chemicals Management Division, EC)
- Stephen McDonald (A/Director, Risk Management Bureau, HC)
- Robert Chénier (Director, Ecological Assessment Division, EC)
- Christine Norman (Director, Existing Substances Risk Assessment Bureau, HC)
- Doug Haines (Director, Chemicals Surveillance Bureau, HC)
- Jake Sanderson (Manager, Horizontal Policy and Planning Section, EC)
- Mike Wade (Research Scientist, Hazard Identification Division, HC)
- Michelle Bowerman (Manager, Program Liaison, EC)
- Roxanne Clément (Coordinator/Officer Environmental Programs, Program Liaison, EC)
- Danielle Schami (Senior Advisor, Stakeholder Engagement Office, HC)
- Dr. Victor Goldbloom, Bruce Cran, Fe de Leon, Keith Mussar, Lorena Ligori, Dr. Lee Wilson, Shelagh Kerr
Government officials provided updates of action items from previous meetings as well as a progress update of current program initiatives.
There were questions related to the release to the environment from substances in Streams 1 and 2. Government clarified that the potential for these substances to be released to the environment was considered in developing the risk assessment even though these substances are site and industry-restricted. There were also questions pertaining to timelines for risk management measures. Government described the timelines and process for risk management activities.
Members indicated that they were finding it challenging to track the progress of all CMP related initiatives and suggested that it would be beneficial to have one place to go to on the Chemical Substances Web site that presented the progress for all related CMP programs, including PSSA, Groupings, Section 71 Notices, etc. Government replied that they would consider developing such a tool.
Agenda Item 1 - Endocrine Modulating Substances: Assessment, Research and International Engagement
HC and EC staff presented an overview of recent activities in the area of endocrine related effects from the perspective of risk assessment, research, monitoring and surveillance, and international engagement, with a focus on the CMP.
The presentation generated commentary from Members including:
There was a discussion regarding the diverse views expressed in the public literature on low-dose effects and on how to test for potential impacts of chemicals at environmentally relevant concentrations. Government officials noted that a number of monitoring and surveillance programs help determine the range in concentration to which Canadians may be exposed.
Agenda Item 2 - Publication of the Canadian Health Measures Survey Cycle 2
HC staff presented the plan for communicating biomonitoring results from Cycle 2 of the Canadian Health Measures Survey (CHMS). As some Council members participated in a working group created by HC to discuss communications challenges around the release of the Cycle 1 results, this presentation was an opportunity to report back on the Cycle 1 public documents and how these will shape publications for Cycle 2. The presentation provided an overview of the CHMS biomonitoring component, summarised the CHMS Cycle 1 release, and described the plan for communicating new biomonitoring results from Cycle 2 of the CHMS.
Additional information was shared through the discussion that ensued:
In March 2013, the Assembly of First Nations will be releasing a report from a similar study that includes people living on reserves south of the 60th parallel, thus complementing the work achieved under the CHMS.
Agenda Item 3 - Europe's REACH and Canada's CMP
EC staff presented an overview of Europe's REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals) Directive and outlined linkages and differences between REACH and Canada's CMP. The presentation also included an analysis of some of the outputs from both programs as well as the path forward.
Agenda Item 4 - Chemicals in Products (CiP)
EC staff provided a brief presentation on chemicals in products to initiate discussions on how to obtain better information on chemicals that are found in products in the market place. Government highlighted some of the challenges related to these substances and suggested three possible approaches. Members were asked to provide feedback on the approaches suggested to explore the opportunity for cooperative engagement with external stakeholders.
Closing Remarks and Proposed Agenda Items
The Co-Chairs thanked the Council Members for their valuable contributions towards all the topics presented during the meeting and identified and clarified the action/follow-up items to be addressed by Government. Members provided positive feedback with regards to the structure, processes and operations of the Council. They also indicated that they were pleased with the content that was presented during the meeting.
The Co-Chairs led a short discussion on potential topics for future Stakeholder Advisory Council Meetings. The following topics were raised as a result of this discussion:
- Use of Science in Regulatory Decision Making
- Quantitative Structure Activity Relationship and modelling
- Approaches taken to assess environmental systems
- Assumptions used in risk assessment
- Discussion on alternative assessments and test methods
- Update on the polymer approach
- Date modified: